Mkt Advisors LLC Merck & Co., Inc. Transaction History

Mkt Advisors LLC

$225 Million
Q4 2024

A detailed history of Mkt Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mkt Advisors LLC holds 5,739 shares of MRK stock, worth $512,951. This represents 0.25% of its overall portfolio holdings.

Number of Shares

5,739

Previous 5,712 0.47%

Holding current value

$512,951

Previous $648,000 12.04%

% of portfolio

0.25%

Previous 0.3%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$96.31 - $114.76 $2,600 - $3,098	27 Added 0.47%	5,739 $570,000
Q2 2024 Jul 12, 2024	BUY	$123.8 - $132.96 $14,113 - $15,157	114 Added 2.04%	5,712 $707,000
Q1 2024 Apr 15, 2024	BUY	$113.24 - $131.95 $51,184 - $59,641	452 Added 8.78%	5,598 $738,000
Q4 2023 Jan 12, 2024	BUY	$100.18 - $109.02 $1,302 - $1,417	13 Added 0.25%	5,146 $561,000
Q3 2023 Oct 12, 2023	SELL	$102.95 - $114.33 $5,559 - $6,173	-54 Reduced 1.04%	5,133 $528,000
Q2 2023 Aug 01, 2023	SELL	$108.61 - $118.38 $138,586 - $151,052	-1,276 Reduced 19.74%	5,187 $598,000
Q1 2023 Apr 10, 2023	SELL	$102.94 - $114.86 $2,367 - $2,641	-23 Reduced 0.35%	6,463 $687,000
Q4 2022 Jan 19, 2023	BUY	$87.44 - $112.11 $4,546 - $5,829	52 Added 0.81%	6,486 $0
Q3 2022 Oct 20, 2022	SELL	$84.53 - $94.96 $253 - $284	-3 Reduced 0.05%	6,434 $554,000
Q2 2022 Aug 09, 2022	SELL	$83.49 - $94.64 $18,033 - $20,442	-216 Reduced 3.25%	6,437 $586,000
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $43,003 - $48,204	585 Added 9.64%	6,653 $583,000
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $438,595 - $549,396	6,068 New	6,068 $480,000

Others Institutions Holding MRK

# of Institutions

3,959

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $226B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mkt Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mkt Advisors LLC with notifications on news.

Account